Viewing Study NCT05578092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-01-14 @ 3:27 PM
Study NCT ID: NCT05578092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-30
First Post: 2022-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway
Sponsor: Mirati Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
None Advanced Solid Tumor View
None Non Small Cell Lung Cancer View
None Colo-rectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non Small Cell Lung Cancer View
None NSCLC View
None Colorectal Cancer View
None CRC View
None EGFR View
None KRAS View
None SOS1 View
None Solid Tumor View
None Advanced Solid Tumor View
None Malignant View